peptide-research
How the Pharmacy Compounding Advisory Committee...
The Pharmacy Compounding Advisory Committee reviews scientific, technical, and medical questions involving human drug compounding and provides recommendations to the FDA. When a peptide-related bulk drug substance is considered for...
How the Pharmacy Compounding Advisory Committee...
The Pharmacy Compounding Advisory Committee reviews scientific, technical, and medical questions involving human drug compounding and provides recommendations to the FDA. When a peptide-related bulk drug substance is considered for...
What Does “Nominated for Evaluation” Mean?
When a bulk drug substance is nominated for evaluation, information has been submitted so FDA can consider whether the substance may be appropriate for inclusion on a compounding-related bulks list....
What Does “Nominated for Evaluation” Mean?
When a bulk drug substance is nominated for evaluation, information has been submitted so FDA can consider whether the substance may be appropriate for inclusion on a compounding-related bulks list....
FDA Approval vs Compounding Eligibility: What I...
FDA approval and compounding eligibility are different regulatory outcomes. FDA approval applies to a defined finished drug product reviewed through an applicable approval pathway. Compounding eligibility concerns whether a product...
FDA Approval vs Compounding Eligibility: What I...
FDA approval and compounding eligibility are different regulatory outcomes. FDA approval applies to a defined finished drug product reviewed through an applicable approval pathway. Compounding eligibility concerns whether a product...
What Is an Active Pharmaceutical Ingredient?
An active pharmaceutical ingredient is the substance intended to provide pharmacological activity or another direct effect in a drug product. It is commonly abbreviated as API. The API is combined...
What Is an Active Pharmaceutical Ingredient?
An active pharmaceutical ingredient is the substance intended to provide pharmacological activity or another direct effect in a drug product. It is commonly abbreviated as API. The API is combined...
What Is the FDA 503A Bulks List?
The FDA 503A Bulks List identifies certain bulk drug substances that may be used in qualifying pharmacy compounding when specific federal conditions are met. It is not a list of...
What Is the FDA 503A Bulks List?
The FDA 503A Bulks List identifies certain bulk drug substances that may be used in qualifying pharmacy compounding when specific federal conditions are met. It is not a list of...
What Does “Insufficient Evidence” Mean in Regul...
“Insufficient evidence” means that the available information does not adequately support the specific conclusion or regulatory action being requested. It does not automatically mean that a substance has been proven...
What Does “Insufficient Evidence” Mean in Regul...
“Insufficient evidence” means that the available information does not adequately support the specific conclusion or regulatory action being requested. It does not automatically mean that a substance has been proven...